Repairing trust in science requires a more inclusive understanding of innovation
By Shobita Parthasarathya,
Science
| 01. 22. 2026
These are extraordinarily challenging times for university researchers across the United States. After decades of government largess based on the idea that a large and well-financed research ecosystem will produce social and economic progress, there have been huge cuts in federal funding. Those applying for remaining scraps face new restrictions designed to ensure their political alignment with the current presidential administration. These policies are destroying scores of careers, as government funding is an important marker of an investigator’s potential and pivotal for securing job offers, promotion, and tenure. It is also necessary to train the next generations of scientists and engineers. As a result, science and innovation may be suffering.
In response, faculty, staff, and students have taken to the streets and to the opinionpages of newspapers and magazines across the country, explaining the social value of their work, of federal grant funding, and of academic freedom. But it’s not clear that these strategies are effective, as they largely assume that the problem is one of scientific communication rather than one of public trust.
Although public trust in...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...